|
 | Up a level |
Sharma, S and Rani, H and Mahesh, Y and Jolly, MK and Dixit, J and Mahadevan, V (2024) Loss of p53 epigenetically modulates epithelial to mesenchymal transition in colorectal cancer. In: Translational Oncology, 43 .
Sengupta, S and Singh, N and Paul, A and Datta, D and Chatterjee, D and Mukherjee, S and Gadhe, L and Devi, J and Mahesh, Y and Jolly, MK and Maji, SK (2023) p53 amyloid pathology is correlated with higher cancer grade irrespective of the mutant or wild-type form. In: Journal of Cell Science, 136 (17).
Banerjee, S and Mahesh, Y and Prabhu, D and Sekar, K and Sen, P (2023) Identification of potent anti-fibrinolytic compounds against plasminogen and tissue-type plasminogen activator employing in silico approaches. In: Journal of Biomolecular Structure and Dynamics .
Subbalakshmi, AR and Sahoo, S and Manjunatha, P and Goyal, S and Kasiviswanathan, VA and Mahesh, Y and Ramu, S and McMullen, I and Somarelli, JA and Jolly, MK (2023) The ELF3 transcription factor is associated with an epithelial phenotype and represses epithelial-mesenchymal transition. In: Journal of Biological Engineering, 17 (1).
Cheemanapalli, S and Palaniappan, C and Mahesh, Y and Iyyappan, Y and Yarrappagaari, S and Kanagaraj, S (2022) In vitro and in silico perspectives to explain anticancer activity of a novel syringic acid analog ((4-(1H-1, 3-benzodiazol-2-yl)-2, 6-dimethoxy phenol)) through apoptosis activation and NFkB inhibition in K562 leukemia cells. In: Computers in Biology and Medicine, 152 .
